Biogen Collaboration With Applied Genetic Is 'Interesting,' But Morgan Stanley Will Wait For More Data
July 06, 2015 at 07:51 AM EDT
In a report published Monday, Morgan Stanley analyst Matthew Harrison maintained an Overweight rating on Biogen Inc (NASDAQ: BIIB). The ...